Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 6/20 | 0.60 |
| ▸ | CCND1 | P24385 | 6/20 | 0.60 |
| ▸ | PLK4 | O00444 | 1/20 | 0.57 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.57 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.57 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.57 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.57 |
| ▸ | METAP2 | P50579 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | PARP1 | P09874 | 2/20 | 0.42 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.42 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.41 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.41 |
| ▸ | CDK1 | P06493 | 1/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.41 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30174980 | 1.00 | CDK4 (0.60) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL1177888 | 0.87 | IMPDH2 (0.55) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL31664385 | 0.87 | IMPDH2 (0.55) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL23039562 | 0.87 | CDK4 (0.61) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL27969034 | 0.84 | IMPDH2 (0.52) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL23945224 | 0.84 | CDK4 (0.71) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL23771654 | 0.84 | CDK4 (0.48) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL27404199 | 0.83 | CDK4 (0.54) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL28435895 | 0.82 | CDK4 (0.47) | CDK4CCND1PLK4MAPK9LIMK1 | |
| SCHEMBL25681710 | 0.82 | CDK4 (0.50) | CDK4CCND1PLK4MAPK9LIMK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117402102-A | Diamine containing carbazole moieties and polyimide gas separation membrane prepared from diamine and method | 西北工业大学 | 2024-01-16 | — | — | CN | claimed |
| CN-117402102-A | Diamine containing carbazole moieties and polyimide gas separation membrane prepared from diamine and method | 西北工业大学 | 2024-01-16 | — | — | CN | disclosed |
| CN-109071622-B | Peptides with anticancer activity | IDP研发制药有限公司（ES） | 2023-01-13 | — | — | CN | disclosed |
| US-20210202864-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | KYULUX, INC. (JP) | 2021-07-01 | — | — | US | disclosed |
| US-20200235313-A1 | COMPOUND, LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2020-07-23 | — | — | US | disclosed |
| WO-2020039708-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | 国立大学法人九州大学 | 2020-02-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235313-A1 | COMPOUND, LIGHT-EMITTING MATERIAL AND LIGHT-EMITTING ELEMENT | LBR, CTNND1, NCL | CDK4 350/4885CCND1 16/4885PLK4 2149/4885 |
| US-20210202864-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT | LEF1, EMC1, EEA1 | CDK4 1035/4885CCND1 144/4885PLK4 3375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.